1st Quarter - Report

PARKINSON'S ACTION NETWORK for PARKINSON'S ACTION NETWORK

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$50,765
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Jul 11, 2016 $50,765 Replaced
1st Quarter - Amendment Apr 20, 2017 $50,765 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Environment/Superfund ENV

"S.697, Frank R. Lautenberg Chemical Safety for the 21st Century Act," all sections.

LobbyistCovered position, as disclosed
JAMES TUCKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 697 (114th)

Medicare/Medicaid MMM

"H.R. 775/S. 539, Medicare Access to Rehabilitation Services Act," all sections;"H.R. 3081/S.1778, The TELE-Med Act, all sections;"H.R. 2624/S. 1488, The Part D Beneficiary Fairness Appeals Act," all sections; "The Veterans E-Health and Telemedicine Support Act," (S. 2170); Medicare support for FDA breakthrough therapies (coalition sign-on support letter)

LobbyistCovered position, as disclosed
JAMES TUCKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3081 (114th), S. 1778 (114th), H.R. 2624 (114th), H.R. 775 (114th), S. 2170 (114th), S. 539 (114th), S. 1488 (114th)

Family issues/Abortion/Adoption FAM

"H.R. 263, Adult Day Center Enhancement Act," all sections; and "S. 1549, The Care Planning Act of 2015," all sections.

LobbyistCovered position, as disclosed
JENNIFER SHERIDAN PALUTE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 263 (114th), S. 1549 (114th)

Medical/Disease Research/Clinical Labs MED

"The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections;

LobbyistCovered position, as disclosed
JAMES TUCKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 849 (114th), H.R. 292 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.